ClinicalTrialsFinder

Phase 2 Acute Graft Versus Host Disease Clinical Trials

9 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–9 of 9 trials

Recruiting
Phase 2

Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Graft Versus Host DiseaseGraft-Versus-Host DiseaseALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology42 enrolled1 locationNCT07572669
Recruiting
Phase 2

MAGIC Ruxolitinib for aGVHD

Acute Graft Versus Host Diseaseadverse effectsAllogeneic Bone Marrow Transplantation
John Levine98 enrolled14 locationsNCT06936566
Recruiting
Phase 1Phase 2

First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)

Acute Graft Versus Host Disease
First Affiliated Hospital of Zhejiang University35 enrolled1 locationNCT07285889
Recruiting
Phase 2

Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model

Acute Graft Versus Host Disease
Institute of Hematology & Blood Diseases Hospital, China174 enrolled1 locationNCT06880419
Recruiting
Phase 2

Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment

Acute Graft Versus Host Disease
Hospital Universitario Dr. Jose E. Gonzalez20 enrolled1 locationNCT06904599
Recruiting
Phase 2

An open label, study to evaluate the safety of Cannabidiol (CBD) for the prevention of Acute Graft-Versus-Host Disease (GVHD) after allogeneic hematopoietic cell transplantation.

Acute Graft Versus Host DiseaseHematopoietic Stem Cell Transplantation
Kalytera Therapeutics Israel Ltd36 enrolled2 locationsACTRN12619000623190
Recruiting
Phase 2

Use of Tocilizumab (TCZ) to prevent acute graft versus host disease (GVHD)

Acute graft versus host disease (GVHD) post HLA-matched allogeneic haematopoietic progenitor cell transplantation (HPCT)
Royal Brisbane and Women's Hospital18 enrolled1 locationACTRN12614000212651
Recruiting
Phase 2

Use of Tocilizumab (TCZ) to prevent acute graft versus host disease (GVHD)

Acute graft versus host disease (GVHD) post HLA-matched allogeneic haematopoietic progenitor cell transplantation (HPCT)
Royal Brisbane and Women's Hospital48 enrolled1 locationACTRN12612000726853
Recruiting
Phase 2

Phase II study of myeloablative allogeneic transplantation using pegylated G-CSF mobilised peripheral blood stem cells.

Acute Graft Versus Host Disease following allogeneic peripheral blood stem cell transplant from am HLA identical sibling for a haematological malignancy.
A/Prof Geoff Hill47 enrolled1 locationACTRN12605000460606